PDS Biotechnology Corp Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
PDS Biotechnology Corp (PDSB) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2021-03-18
- PDS Biotechnology Corp impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PDS Biotechnology Corp impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2019 was $2.97M.
- PDS Biotechnology Corp impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2018 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2019-12-31 | $2.97M 10-K · filed 2021-03-18 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |